A rigorous systematic review of the present state of knowledge on the use of acetaminophen during pregnancy and the risk of specific neurodevelopmental disorders (NDDs), such as autism… read more.
Thousands of people in England and Wales with severe osteoporosis who are at high risk of fracture are set to benefit from a new treatment – romosozumab (Evenity™,… read more.
Community pharmacists can be an important source of information about cannabidiol (CBD) but they also need to ensure that the CBD products that they sell are correctly licensed… read more.
Natural cannabidiol distillate is superior to synthetic CBD because of the benefits of the ‘entourage effect’, according to Moyra Cosgrove, Head of Nutrition for Naturecan, a company that… read more.
There is a growing body of evidence for the effectiveness of cannabidiol (CBD) in a number of health conditions. To find out more, IMI spoke to Moyra Cosgrove,… read more.
Improved detection of atrial fibrillation could prevent disabling strokes. A clinical trial examining the efficacy of two devices to monitor and detect atrial fibrillation (AF), or an irregular… read more.
A new study from Columbia University and an international team of researchers identifies multiple ways to achieve the same health benefits from exercise — as long as the… read more.
Asthma afflicts more than 300 million people worldwide. The most severe manifestation, known as non-Th2, or non-atopic childhood asthma, represents the majority of the cases, greater than 85%,… read more.
A new study from the University of Surrey has found that among people aged 55 to 75 more frequent use of the internet was beneficial for mental health… read more.
In a worldwide study of 2,100 pregnant women, those who contracted COVID-19 during pregnancy were 20 times more likely to die than those who did not contract the… read more.
Exclusively using (or “vaping”) e-cigarettes can help people quit smoking, but many people using e-cigarettes to quit smoking continue to smoke cigarettes.
Researchers from the University of Oxford and their partners have today reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
